US$289,525
US$181,694
19.6%
US$124,902
US$46,631
US$10,887
-US$726
US$4,682
/yr
Portfolio
US Market
A past performer with good growth potential
14 holdings
14
Symbol | Price Vs Fair Value | 7D Return | Total Return | Value & Cost | Weight & Shares | Avg. Price | 1Y chart | |
---|---|---|---|---|---|---|---|---|
META Meta Platforms | US$773.44 23.0% undervalued intrinsic discount | 8.2% +US$4,984 | 349.1% +US$55,370 | US$65,742 US$13,830 | 22.7% 85 | US$162.71 | ||
BATS British American Tobacco | UK£40.40 44.9% undervalued intrinsic discount | 3.2% +US$1,174 | 34.0% +US$13,120 | US$37,348 US$26,990 | 12.9% 700 | UK£30.00 | ||
NVDA NVIDIA | US$177.87 36.7% overvalued intrinsic discount | 2.4% +US$165 | 869.7% +US$15,092 | US$7,115 US$1,443 | 2.5% 40 | US$36.06 | ||
PLTR Palantir Technologies | US$158.35 160.9% overvalued intrinsic discount | 2.3% +US$349 | 831.5% +US$14,135 | US$15,835 US$1,700 | 5.5% 100 | US$17.00 | ||
TSLA Tesla | US$308.27 81.9% overvalued intrinsic discount | 1.0% +US$297 | 39.5% +US$8,727 | US$30,827 US$22,100 | 10.6% 100 | US$221.00 | ||
AMZN Amazon.com | US$234.11 31.8% undervalued intrinsic discount | 0.8% +US$107 | 68.2% +US$5,658 | US$13,344 US$7,775 | 4.6% 57 | US$136.41 | ||
XOM Exxon Mobil | US$111.64 57.7% undervalued intrinsic discount | 0.8% +US$174 | 100.1% +US$12,993 | US$22,886 US$12,897 | 7.9% 205 | US$62.91 | ||
TLX Telix Pharmaceuticals | AU$21.05 54.0% undervalued intrinsic discount | 0.4% +US$35.99 | 107.2% +US$7,856 | US$9,469 US$5,128 | 3.3% 700 | AU$11.00 | ||
OKTA Okta | US$97.84 32.0% undervalued intrinsic discount | -0.05% -US$4.16 | -51.1% -US$8,173 | US$7,827 US$16,000 | 2.7% 80 | US$200.00 | ||
JPM JPMorgan Chase | US$296.24 22.0% undervalued intrinsic discount | -0.1% -US$15.50 | 46.9% +US$4,927 | US$14,812 US$10,500 | 5.1% 50 | US$210.00 | ||
CRWD CrowdStrike Holdings | US$454.57 6.1% undervalued intrinsic discount | -1.6% -US$373 | 61.0% +US$11,034 | US$22,729 US$13,100 | 7.9% 50 | US$262.00 | ||
BAC Bank of America | US$47.27 29.8% undervalued intrinsic discount | -2.3% -US$672 | 61.7% +US$11,782 | US$28,362 US$19,100 | 9.8% 600 | US$31.83 | ||
JNJ Johnson & Johnson | US$164.74 36.8% undervalued intrinsic discount | -2.8% -US$241 | 74.5% +US$3,801 | US$8,237 US$5,100 | 2.8% 50 | US$102.00 | ||
UNH UnitedHealth Group | US$249.56 78.3% undervalued intrinsic discount | -10.4% -US$580 | -38.1% -US$3,416 | US$4,991 US$8,960 | 1.7% 20 | US$448.00 |
There are three easy ways to get started:
Simply Wall St goes far beyond price tracking. You'll be able to:
Most brokers and portfolio trackers only show prices and unrealised gains, with little context and lots of noisy news. Simply Wall St offers:
In short, Simply Wall St is more than a tracker — it's a complete investing platform for monitoring, analysing, and growing your portfolio.
Have feedback on the portfolio tool?